½ÃÀ庸°í¼­
»óǰÄÚµå
1586074

ij´¼¶ó ½ÃÀå : Á¦Ç°, Àç·á, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Cannula Market by Product (Arthroscopy Cannulas, Cardiac Cannulas, Dermatology Cannulas), Material (Metal Cannulas, Plastic Cannulas, Silicone Cannulas), Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 197 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ij´¼¶ó ½ÃÀåÀº 2023³â¿¡ 3¾ï 293¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 3¾ï 1,933¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 5.50%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 4¾ï 4,088¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ij´¼¶ó´Â Á¤¸ÆÀ̳ª ü°­¿¡ »ðÀÔÇÏ¿© ¾à¹° Åõ¿©, ü¾× ¹èÃâ, ¼ö¼ú ±â±¸ µµÀÔ µîÀ» À§ÇØ »ç¿ëµÇ´Â °¡´À´Ù¶õ °üÀ» ¸»ÇÕ´Ï´Ù. ij´¼¶óÀÇ Çʿ伺Àº ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡¼­ ¿Ü»óÀ» ÃÖ¼ÒÈ­Çϸ鼭 Á¢±ÙÀ» °¡´ÉÇÏ°Ô ÇÏ´Â Áß¿äÇÑ ¿ªÇÒ¿¡¼­ ºñ·ÔµË´Ï´Ù. ij´¼¶ó´Â ¿Ü°ú ¼ö¼ú, Á¤¸ÆÁÖ»ç, ¹Ì¿ë ÀÇ·á µî ÀÇ·á ºÐ¾ß¿¡¼­ ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ°í ÀÖÀ¸¸ç, ÃÖÁ¾ ¿ëµµ´Â º´¿ø, Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ÀçÅÃÄ¡·á µî ´Ù¾çÇÑ ºÐ¾ß¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ij´¼¶ó ½ÃÀåÀÇ ¼ºÀåÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀÇ·á ºÐ¾ßÀÇ ±â¼ú ¹ßÀü µîÀÇ ¿äÀο¡ ÀÇÇØ Å©°Ô °ßÀεǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀçÅÃÄ¡·á Æ®·»µå, ³ëÀÎ Àα¸ Áõ°¡, ÀÇ·áºñ Áõ°¡´Â ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¾ÈÀü¼ºÀÌ °­È­µÈ ÷´Ü ij´¼¶ó, »ýüÀûÇÕ¼º ¼ÒÀç, ÅëÇÕ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ µîÀÇ °³¹ß¿¡´Â ¸¹Àº ºñÁî´Ï½º ±âȸ°¡ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ ±â¾÷µéÀº ¿¬±¸°³¹ß°ú ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿ÍÀÇ Àü·«Àû Á¦ÈÞ¿¡ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù. ±×·¯³ª ½ÃÀåÀº ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ÷´Ü ij´¼¶ó ±â¼ú°ú °ü·ÃµÈ ³ôÀº ºñ¿ë, °¨¿° ¹× Ç÷ÀüÁõ°ú °°Àº ÀáÀçÀû ÇÕº´Áõ°ú °°Àº Á¦¾à¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§Çؼ­´Â Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å°ú ÁøÈ­ÇÏ´Â ÀÇ·á Ç¥ÁØÀ» ÁؼöÇØ¾ß ÇÕ´Ï´Ù. Çõ½Å ºÐ¾ß¿¡´Â ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× Çǵå¹éÀ» À§ÇÑ ¼¾¼­ ÀÏüÇü ij´¼¶ó¿Í °°Àº ½º¸¶Æ® ij´¼¶ó ±â¼úÀÌ Æ÷ÇԵǸç, À̸¦ ÅëÇØ ȯÀÚ °á°ú¸¦ Å©°Ô °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ij´¼¶ó ½ÃÀåÀº °æÀïÀÌ Ä¡¿­ÇÏÁö¸¸ ¼¼ºÐÈ­µÇ¾î ÀÖÀ¸¸ç, ÁÖ¿ä ¾÷üµéÀº ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­Çϱâ À§ÇØ ²÷ÀÓ¾øÀÌ M&A¸¦ ¸ð»öÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °³¹ßµµ»ó±¹Àº ÇコÄɾî ÅõÀÚ Áõ°¡¿Í ÀÎ½Ä Áõ°¡·Î ÀÎÇØ ¹Ì°³Ã´ ÀáÀç·ÂÀÌ Å« ½ÃÀåÀ¸·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ß¿¡ ÁøÃâÇÏ´Â ±â¾÷Àº ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼Ç°ú ƯÁ¤ ÀÇ·á ¿ä±¸¿¡ ¸Â´Â ¸ÂÃãÇü ij´¼¶ó ¼³°è¿¡ ÁßÁ¡À» µÎ¾î °æÀï·ÂÀ» ³ôÀÌ°í ºñÁî´Ï½ºÀÇ »ó´çÇÑ ¼ºÀåÀÇ ±æÀ» ¿­ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 3¾ï 293¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 3¾ï 1,933¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 4¾ï 4,088¸¸ ´Þ·¯
CAGR(%) 5.50%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­Çϴ ij´¼¶ó ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ij´¼¶ó ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °í·ÉÈ­ »çȸ·Î ÀÎÇÑ ¼ö¼ú °Ç¼ö Áõ°¡
    • ½ÉÇ÷°ü ÁúȯÀÇ ³ôÀº À¯º´·ü
    • ÃÖ¼Òħ½À¼ö¼ú(MIS)¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Á¦Ç° ȸ¼ö °ü·Ã ¹®Á¦
  • ½ÃÀå ±âȸ
    • ij´¼¶óÀÇ Áö¼ÓÀûÀÎ ¿¬±¸¿Í ¹ßÀü
    • º¸°ÇÀÇ·á ÀÎÇÁ¶ó ¹× ÁöÃâ °³¼±
  • ½ÃÀå °úÁ¦
    • ¾ö°ÝÇÑ ½ÂÀÎ Áöħ ¹× ±ÔÁ¦

Portre's Five Forces: ij´¼¶ó ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

Porter's Five ForcesÀº ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÆÄ¾ÇÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. PorterÀÇ Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ij´¼¶ó ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ij´¼¶ó ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ij´¼¶ó ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

ij´¼¶ó ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ij´¼¶ó ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ij´¼¶ó ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ij´¼¶ó ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× Ãßõ ij´¼¶ó ½ÃÀå¿¡¼­ÀÇ ¼º°ø °æ·Î¸¦ ±×¸®´Ù.

ij´¼¶ó ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ij´¼¶ó ½ÃÀå : Á¦Ç°º°

  • °üÀý°æ ij´¼¶ó
  • ½ÉÀå ij´¼¶ó
  • ÇǺΰú¿ë ij´¼¶ó
  • ÄÚ Ä³´¼¶ó
  • Ç÷°ü ij´¼¶ó

Á¦7Àå ij´¼¶ó ½ÃÀå : ¼ÒÀ纰

  • ±Ý¼Ó ij´¼¶ó
  • ÇÃ¶ó½ºÆ½ ij´¼¶ó
  • ½Ç¸®ÄÜ Ä³´¼¶ó

Á¦8Àå ij´¼¶ó ½ÃÀå : ¿ëµµº°

  • ½ÉÀåÇ÷°ü ¿Ü°ú
  • ¹Ì¿ë¼ºÇü ¼ö¼ú
  • ´ç´¢º´ Ä¡·á
  • ÀϹݿܰú
  • Á¤Çü¿Ü°ú
  • »ê¼Ò ¿ä¹ý

Á¦9Àå ij´¼¶ó ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ç÷¾×ÀºÇà ¹× ÀçÅà ÀÇ·á½Ã¼³
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Ä³´¼¶ó ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ä³´¼¶ó ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ä³´¼¶ó ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Acti-Med GmbH by Gilde Healthcare Partners BV
  • Advin Health Care
  • Angiplast Pvt. Ltd.
  • B. Braun SE
  • Boston Scientific Corporation
  • Cadence Inc.
  • CONMED Corporation
  • DLK Medical Technologies, Inc.
  • Edward Lifescience Corporation
  • Getinge AB
  • GPC Medical Ltd.
  • GWS Surgicals LLP
  • LivaNova, PLC
  • Mais India Medical Devices
  • Medilivescare Manufacturing Pvt. Ltd.
  • MediPlus India Limited
  • Medtronic PLC
  • NEEDLETECH, Corp.
  • Novosci Corporation
  • Smith & Nephew PLC
  • SunMed, LLC
  • SURGITECH INNOVATION
  • Teleflex, Inc.
  • Terumo Corporation
LSH

The Cannula Market was valued at USD 302.93 million in 2023, expected to reach USD 319.33 million in 2024, and is projected to grow at a CAGR of 5.50%, to USD 440.88 million by 2030.

A cannula is a thin tube inserted into a vein or body cavity to administer medication, drain off fluid, or introduce surgical instruments. The necessity for cannulas arises from their critical role in minimally invasive procedures, enabling access while minimizing trauma. They are widely applied in medical fields such as surgery, intravenous therapy, and aesthetic medicine, with end-use scope spanning hospitals, clinics, ambulatory surgical centers, and home healthcare settings. Market growth for cannulas is significantly driven by factors such as the rising prevalence of chronic diseases, increased demand for minimally invasive surgical procedures, and technological advancements in healthcare. Moreover, the trend of home healthcare, expanding geriatric population, and rising healthcare expenditure further bolster market expansion. Opportunities abound in the development of advanced cannulas with enhanced safety features, biocompatible materials, and integrated monitoring systems. To capitalize on these opportunities, companies should focus on R&D and strategic partnerships with healthcare providers. However, the market faces limitations such as stringent regulatory requirements, high costs associated with advanced cannula technologies, and potential complications like infection and thrombosis. Addressing these challenges requires continuous innovation and adherence to evolving medical standards. Areas of innovation include smart cannula technologies like sensor-integrated cannulas for real-time monitoring and feedback, which can significantly improve patient outcomes. The nature of the cannula market is competitive but fragmented, with key players continually exploring mergers and acquisitions to strengthen their market position. Additionally, developing regions offer immense untapped potential due to increasing healthcare investments and rising awareness. Businesses venturing into this domain need to focus on cost-effective solutions and customized cannula designs catering to specific medical needs, which can provide a competitive edge and open avenues for substantial business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 302.93 million
Estimated Year [2024] USD 319.33 million
Forecast Year [2030] USD 440.88 million
CAGR (%) 5.50%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cannula Market

The Cannula Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of surgeries among the aging population
    • High prevalence rate of cardiovascular diseases
    • Rising demand for minimally invasive surgery (MIS)
  • Market Restraints
    • Issues associated with product recall
  • Market Opportunities
    • Ongoing research and advancements in cannulas
    • Improved healthcare infrastructure and spending
  • Market Challenges
    • Stringent approval guidelines and regulations

Porter's Five Forces: A Strategic Tool for Navigating the Cannula Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cannula Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cannula Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cannula Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cannula Market

A detailed market share analysis in the Cannula Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cannula Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cannula Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cannula Market

A strategic analysis of the Cannula Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cannula Market, highlighting leading vendors and their innovative profiles. These include Acti-Med GmbH by Gilde Healthcare Partners BV, Advin Health Care, Angiplast Pvt. Ltd., B. Braun SE, Boston Scientific Corporation, Cadence Inc., CONMED Corporation, DLK Medical Technologies, Inc., Edward Lifescience Corporation, Getinge AB, GPC Medical Ltd., GWS Surgicals LLP, LivaNova, PLC, Mais India Medical Devices, Medilivescare Manufacturing Pvt. Ltd., MediPlus India Limited, Medtronic PLC, NEEDLETECH, Corp., Novosci Corporation, Smith & Nephew PLC, SunMed, LLC, SURGITECH INNOVATION, Teleflex, Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Cannula Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Arthroscopy Cannulas, Cardiac Cannulas, Dermatology Cannulas, Nasal Cannulas, and Vascular Cannulas.
  • Based on Material, market is studied across Metal Cannulas, Plastic Cannulas, and Silicone Cannulas.
  • Based on Application, market is studied across Cardiovascular Surgery, Cosmetic or Plastic Surgery, Diabetes Treatment, General Surgery, Orthopedic Surgery, and Oxygen Therapy.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Blood Banks & Home Healthcare Facilities, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of surgeries among the aging population
      • 5.1.1.2. High prevalence rate of cardiovascular diseases
      • 5.1.1.3. Rising demand for minimally invasive surgery (MIS)
    • 5.1.2. Restraints
      • 5.1.2.1. Issues associated with product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and advancements in cannulas
      • 5.1.3.2. Improved healthcare infrastructure and spending
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent approval guidelines and regulations
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cannula Market, by Product

  • 6.1. Introduction
  • 6.2. Arthroscopy Cannulas
  • 6.3. Cardiac Cannulas
  • 6.4. Dermatology Cannulas
  • 6.5. Nasal Cannulas
  • 6.6. Vascular Cannulas

7. Cannula Market, by Material

  • 7.1. Introduction
  • 7.2. Metal Cannulas
  • 7.3. Plastic Cannulas
  • 7.4. Silicone Cannulas

8. Cannula Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgery
  • 8.3. Cosmetic or Plastic Surgery
  • 8.4. Diabetes Treatment
  • 8.5. General Surgery
  • 8.6. Orthopedic Surgery
  • 8.7. Oxygen Therapy

9. Cannula Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Blood Banks & Home Healthcare Facilities
  • 9.4. Hospitals

10. Americas Cannula Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cannula Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cannula Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acti-Med GmbH by Gilde Healthcare Partners BV
  • 2. Advin Health Care
  • 3. Angiplast Pvt. Ltd.
  • 4. B. Braun SE
  • 5. Boston Scientific Corporation
  • 6. Cadence Inc.
  • 7. CONMED Corporation
  • 8. DLK Medical Technologies, Inc.
  • 9. Edward Lifescience Corporation
  • 10. Getinge AB
  • 11. GPC Medical Ltd.
  • 12. GWS Surgicals LLP
  • 13. LivaNova, PLC
  • 14. Mais India Medical Devices
  • 15. Medilivescare Manufacturing Pvt. Ltd.
  • 16. MediPlus India Limited
  • 17. Medtronic PLC
  • 18. NEEDLETECH, Corp.
  • 19. Novosci Corporation
  • 20. Smith & Nephew PLC
  • 21. SunMed, LLC
  • 22. SURGITECH INNOVATION
  • 23. Teleflex, Inc.
  • 24. Terumo Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦